Latest News

This year marks the Immune Tolerance Network's 10th anniversary!

Results of an Immune Tolerance Network clinical trial may provide doctors with another weapon in the treatment of ANCA-associated vasculitis, which has seen no new approved treatments in 40 years. The study, published in the New England Journal of Medicine, showed that the drug rituximab provides the same treatment benefits as the existing standard of care, and appears to offer additional benefits to those suffering relapses.

On December 23rd, 1953 at the Peter Bent Brigham Hospital in Boston, a team of surgeons carefully removed a healthy kidney from a 23-year-old man named Ronald Herrick. Working quickly, they wrapped the donor organ in a cold, wet towel, placed it in a stainless steel dish, and carried it into a different operating room. There, Ronald’s identical twin Richard lay dying of chronic nephritis. His brother’s healthy kidney was his only chance at survival.The transplant, led by Dr.